Quarterly report · Q2
4480.TEDINET S100OZ47
Period2022-01-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥10.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥1.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥838m | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥743m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥850m | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥873m | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥969m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥563m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥589m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥970m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥585m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥20.9bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥22.2bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.2bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥6.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥14.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.8bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.6bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.3bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.1bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥795m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥366m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥449m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.2bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥30.32 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.29 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.82 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.62 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.71 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.15 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.06 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥1.1bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥224m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥160m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥160m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥24m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | ¥2.3bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥883m |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥229m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥118m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥118m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥31m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥4.1bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥4.1bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-01-01 → 2021-06-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-01-01 → 2021-06-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-01-01 → 2021-06-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 508
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | CurrentYTDDuration | 1403000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 128000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 191000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 53000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 79000000 | JPY |
| Amortization of security deposit ope cf | Prior1YTDDuration | 3000000 | JPY |
| Amortization of security deposit ope cf | CurrentYTDDuration | 15000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 6000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 4000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -0 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -0 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 10000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 6000000 | JPY |
| Amortization of stock issuance cost ope cf | Prior1YTDDuration | 10000000 | JPY |
| Amortization of stock issuance cost ope cf | CurrentYTDDuration | 16000000 | JPY |
| Settlement received ope cf | Prior1YTDDuration | -14000000 | JPY |
| Settlement received ope cf | CurrentYTDDuration | -163000000 | JPY |
| Loss on abandonment of noncurrent assets ope cf | Prior1YTDDuration | 0 | JPY |
| Loss on abandonment of noncurrent assets ope cf | CurrentYTDDuration | 0 | JPY |
| Loss on sales of non current assets ope cf | Prior1YTDDuration | － | JPY |
| Loss on sales of non current assets ope cf | CurrentYTDDuration | 1000000 | JPY |
| Loss gain on transfer of business ope cf | Prior1YTDDuration | -23000000 | JPY |
| Loss gain on transfer of business ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -151000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -159000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 11000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -25000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 15000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -26000000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -24000000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | 96000000 | JPY |
| Increase decrease in advances received ope cf | Prior1YTDDuration | 56000000 | JPY |
| Increase decrease in advances received ope cf | CurrentYTDDuration | -1000000000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in contract liabilities ope cf | CurrentYTDDuration | 855000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -75000000 | JPY |
| Other net ope cf | CurrentYTDDuration | 98000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 882000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 1394000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 0 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 0 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -10000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -5000000 | JPY |
| Settlement package received ope cf | Prior1YTDDuration | 8000000 | JPY |
| Settlement package received ope cf | CurrentYTDDuration | 137000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -85000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -272000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 795000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 1254000000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -200000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |